Stock EMBI SKYE BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Skye Bioscience, Inc.

Equities

EMBI

US83086J2006

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
11.61 USD -0.34% Intraday chart for Skye Bioscience, Inc. -3.73% +326.84%
May. 10 Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index CI

Evolution of the average Target Price on Skye Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d22957.Bf5Hp2MVu_UpfjZoYlzLQrmqS-bXLropqbhE01sP-Ek.T7I0zxJSjZBxCAQ3IB6JCdvvIdOAQdde8dccgAs2k3BzhhTLLXbds34Gew~057381b298de1b2fe7fe79767cf8596d

Analyst Recommendations on Skye Bioscience, Inc.

Piper Sandler Adjusts Skye Bioscience Price Target to $20 From $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.61 USD
Average target price
22 USD
Spread / Average Target
+89.49%
High Price Target
25 USD
Spread / Highest target
+115.33%
Low Price Target
20 USD
Spread / Lowest Target
+72.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Skye Bioscience, Inc.

Piper Sandler

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EMBI Stock
  4. Consensus Skye Bioscience, Inc.